Yujie Chen1, Yang Zhang1, Junjia Tang1, Fei Liu1, Qin Hu1, Chunxia Luo1, Jiping Tang1, Hua Feng1, John H Zhang2. 1. From the Departments of Neurosurgery (Y.C., H.F.) and Neurology (C.L.), Southwest Hospital, Third Military Medical University, Chongqing, China; and Department of Physiology and Pharmacology, Loma Linda University, CA (Y.C., Y.Z., J.T., F.L., Q.H., J.T., J.H.Z.). 2. From the Departments of Neurosurgery (Y.C., H.F.) and Neurology (C.L.), Southwest Hospital, Third Military Medical University, Chongqing, China; and Department of Physiology and Pharmacology, Loma Linda University, CA (Y.C., Y.Z., J.T., F.L., Q.H., J.T., J.H.Z.). johnzhang3910@yahoo.com fenghua8888@vip.163.com.
Abstract
BACKGROUND AND PURPOSE: Norrin and its receptor Frizzled-4 have important roles in the blood-brain barrier development. This study is to investigate a potential role and mechanism of Norrin/Frizzled-4 on protecting blood-brain barrier integrity after subarachnoid hemorrhage (SAH). METHODS: One hundred and seventy-eight male Sprague-Dawley rats were used. SAH model was induced by endovascular perforation. Frizzled-4 small interfering RNA was injected intracerebroventricularly 48 hours before SAH. Norrin was administrated intracerebroventricularly 3 hours after SAH. SAH grade, neurological scores, brain water content, Evans blue extravasation, western blots, and immunofluorescence were used to study the mechanisms of Norrin and its receptor regulation protein TSPAN12, as well as neurological outcome. RESULTS: Endogenous Norrin and TSPAN12 expression were increased after SAH, and Norrin was colocalized with astrocytes marker glial fibrillary acidic protein in cortex. Exogenous Norrin treatment significantly alleviated neurobehavioral dysfunction, reduced brain water content and Evans blue extravasation, promoted β-catenin nuclear translocation, and increased Occludin, VE-Cadherin, and ZO-1 expressions. These effects were abolished by Frizzled-4 small interfering RNA pretreated before SAH. CONCLUSIONS: Norrin protected blood-brain barrier integrity and improved neurological outcome after SAH, and the action of Norrin appeared mediated by Frizzled-4 receptor activation, which promoted β-catenin nuclear translocation, which then enhanced Occludin, VE-Cadherin, and ZO-1 expression. Norrin might have potential to protect blood-brain barrier after SAH.
BACKGROUND AND PURPOSE:Norrin and its receptor Frizzled-4 have important roles in the blood-brain barrier development. This study is to investigate a potential role and mechanism of Norrin/Frizzled-4 on protecting blood-brain barrier integrity after subarachnoid hemorrhage (SAH). METHODS: One hundred and seventy-eight male Sprague-Dawley rats were used. SAH model was induced by endovascular perforation. Frizzled-4 small interfering RNA was injected intracerebroventricularly 48 hours before SAH. Norrin was administrated intracerebroventricularly 3 hours after SAH. SAH grade, neurological scores, brain water content, Evans blue extravasation, western blots, and immunofluorescence were used to study the mechanisms of Norrin and its receptor regulation protein TSPAN12, as well as neurological outcome. RESULTS: Endogenous Norrin and TSPAN12 expression were increased after SAH, and Norrin was colocalized with astrocytes marker glial fibrillary acidic protein in cortex. Exogenous Norrin treatment significantly alleviated neurobehavioral dysfunction, reduced brain water content and Evans blue extravasation, promoted β-catenin nuclear translocation, and increased Occludin, VE-Cadherin, and ZO-1 expressions. These effects were abolished by Frizzled-4 small interfering RNA pretreated before SAH. CONCLUSIONS:Norrin protected blood-brain barrier integrity and improved neurological outcome after SAH, and the action of Norrin appeared mediated by Frizzled-4 receptor activation, which promoted β-catenin nuclear translocation, which then enhanced Occludin, VE-Cadherin, and ZO-1 expression. Norrin might have potential to protect blood-brain barrier after SAH.
Authors: John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce Journal: Nat Rev Neurol Date: 2012-10-16 Impact factor: 42.937
Authors: Yanshu Wang; Amir Rattner; Yulian Zhou; John Williams; Philip M Smallwood; Jeremy Nathans Journal: Cell Date: 2012-12-07 Impact factor: 41.582
Authors: Sheng Chen; Qingyi Ma; Paul R Krafft; Yujie Chen; Jiping Tang; Jianmin Zhang; John H Zhang Journal: Crit Care Med Date: 2013-12 Impact factor: 7.598
Authors: Alin Vonica; Neha Bhat; Keith Phan; Jinbai Guo; Lăcrimioara Iancu; Jessica A Weber; Amir Karger; John W Cain; Etienne C E Wang; Gina M DeStefano; Anne H O'Donnell-Luria; Angela M Christiano; Bruce Riley; Samantha J Butler; Victor Luria Journal: Dev Biol Date: 2020-04-19 Impact factor: 3.582
Authors: Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi Journal: J Cereb Blood Flow Metab Date: 2018-05-08 Impact factor: 6.200